Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-06
DOI
10.3389/fimmu.2019.01990
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
- (2018) Sarah Brown et al. HEALTH TECHNOLOGY ASSESSMENT
- Rituximab in refractory myasthenia gravis: extended prospective study results
- (2018) Grayson Beecher et al. MUSCLE & NERVE
- IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy
- (2018) Giacomo Quattrocchio et al. Oncotarget
- Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome
- (2018) Biswanath Basu et al. JAMA Pediatrics
- Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis
- (2017) Sisi Jing et al. JOURNAL OF NEUROIMMUNOLOGY
- Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
- (2017) Zahra Nikoo et al. JOURNAL OF NEUROLOGY
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
- (2017) Simon J. Bowman et al. Arthritis & Rheumatology
- A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
- (2016) Marc Michel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis
- (2016) Christine Lebrun et al. JOURNAL OF NEUROIMMUNOLOGY
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- (2016) Karine Dahan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
- (2016) Duncan Porter et al. LANCET
- Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
- (2016) Dustin Anderson et al. Annals of Clinical and Translational Neurology
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy
- (2016) Kelly W Burak et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
- (2015) O. Boyman et al. ALLERGY
- Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis
- (2015) I. Fleury et al. ANNALS OF ONCOLOGY
- Rituximab for IgG4-related disease: a prospective, open-label trial
- (2015) Mollie N Carruthers et al. ANNALS OF THE RHEUMATIC DISEASES
- Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years
- (2015) Motohisa Yamamoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
- (2015) Rachel B Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study
- (2015) Luca Quartuccio et al. JOURNAL OF AUTOIMMUNITY
- Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
- (2015) Marius N. Stan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
- (2015) Mario Salvi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial
- (2015) P. Ravani et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Waleed Ghanima et al. LANCET
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
- (2014) Charles Peterfy et al. ANNALS OF THE RHEUMATIC DISEASES
- An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial
- (2014) Edward M Vital et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease
- (2014) T. S. Uldrick et al. BLOOD
- Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study
- (2014) A.J. Kanwar et al. BRITISH JOURNAL OF DERMATOLOGY
- Effect of Rituximab on Serum Levels of Anti-C1q and Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus Nephritis
- (2014) Jin Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
- (2014) Kazumoto Iijima et al. LANCET
- Adverse reactions to biologic agents and their medical management
- (2014) Onur Boyman et al. Nature Reviews Rheumatology
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
- (2014) E. M. Miloslavsky et al. Arthritis & Rheumatology
- Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
- (2013) S. Gudbrandsdottir et al. BLOOD
- A phase III randomized trial comparing glucocorticoid monotherapyversusglucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
- (2013) Henrik Birgens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
- (2013) Russell P. Hall et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome
- (2013) Pietro Ravani et al. KIDNEY INTERNATIONAL
- Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis
- (2013) Feng Sun et al. MUSCLE & NERVE
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare
- (2012) In-Ho Song et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab in psoriatic arthritis: an exploratory evaluation
- (2012) Esther Jimenez-Boj et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
- (2012) Doruk Erkan et al. ARTHRITIS AND RHEUMATISM
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial
- (2012) Chester V. Oddis et al. ARTHRITIS AND RHEUMATISM
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
- (2012) D. M. Arnold et al. BLOOD
- Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
- (2012) A. Magnasco et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-lasting treatment effect of rituximab in MuSK myasthenia
- (2012) J. Diaz-Manera et al. NEUROLOGY
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial
- (2011) Maria W. Greenwald et al. ARTHRITIS AND RHEUMATISM
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis
- (2011) Michael C. Sneller et al. ARTHRITIS AND RHEUMATISM
- A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
- (2011) S. De Vita et al. ARTHRITIS AND RHEUMATISM
- Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
- (2011) P. Ravani et al. Clinical Journal of the American Society of Nephrology
- Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
- (2011) Ekaterina I. Alexeeva et al. CLINICAL RHEUMATOLOGY
- Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
- (2011) K. Leiper et al. GUT
- Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Rituximab Therapy
- (2011) A. E. Berden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for the Treatment of IgG4-Related Disease
- (2011) Arezou Khosroshahi et al. MEDICINE
- Rituximab in anti-glomerular basement membrane disease
- (2011) Y. Shah et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Rituximab for severe myasthenia gravis - experience from five patients
- (2010) C. Lindberg et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial
- (2010) I.-H. Song et al. ARTHRITIS AND RHEUMATISM
- Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease
- (2010) Arezou Khosroshahi et al. ARTHRITIS AND RHEUMATISM
- Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
- (2010) F. Zaja et al. BLOOD
- Pegylated interferon- , ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
- (2010) F. Dammacco et al. BLOOD
- Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
- (2010) Zhenyu Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)
- (2010) Fereydoun DAVATCHI et al. International Journal of Rheumatic Diseases
- Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
- (2010) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
- Repeated courses of rituximab in chronic ITP: Three different regimens
- (2009) Aisha Hasan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis
- (2009) J Narvaez et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Rituximab for myasthenia gravis
- (2009) Karl Stieglbauer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
- (2009) Dimitrios Daoussis et al. RHEUMATOLOGY
- Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate
- (2008) K Owczarczyk et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
- (2008) E Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of refractory generalized myasthenia gravis with rituximab
- (2008) C. Lebrun et al. EUROPEAN JOURNAL OF NEUROLOGY
- Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients
- (2008) Isabel Illa et al. JOURNAL OF NEUROIMMUNOLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: A case series
- (2007) Alain Bestawros et al. AMERICAN JOURNAL OF HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now